174 related articles for article (PubMed ID: 38413794)
21. WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.
Ponce RKM; Thomas NJ; Bui NQ; Kondo T; Okimoto RA
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315355
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features of undifferentiated round cell sarcomas of bone & soft tissues: An attempt to unravel the
Rekhi B; Kembhavi P; Mishra SN; Shetty O; Bajpai J; Puri A
Indian J Med Res; 2019 Dec; 150(6):557-574. PubMed ID: 32048619
[TBL] [Abstract][Full Text] [Related]
23. CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analysis of seven cases.
Gambarotti M; Benini S; Gamberi G; Cocchi S; Palmerini E; Sbaraglia M; Donati D; Picci P; Vanel D; Ferrari S; Righi A; Dei Tos AP
Histopathology; 2016 Oct; 69(4):624-34. PubMed ID: 27079694
[TBL] [Abstract][Full Text] [Related]
24. CIC-Rearranged Sarcoma.
Makise N; Yoshida A
Surg Pathol Clin; 2024 Mar; 17(1):141-151. PubMed ID: 38278603
[TBL] [Abstract][Full Text] [Related]
25. CIC-DUX4 sarcoma diagnosed by fine-needle aspiration cytology: A case report.
Tang S; Dodd LG
Diagn Cytopathol; 2018 Nov; 46(11):958-963. PubMed ID: 30353686
[TBL] [Abstract][Full Text] [Related]
26. Expanding the Molecular Diversity of CIC-Rearranged Sarcomas With Novel and Very Rare Partners.
Linos K; Dermawan JK; Bale T; Rosenblum MK; Singer S; Tap W; Dickson MA; Hornick JL; Antonescu CR
Mod Pathol; 2023 May; 36(5):100103. PubMed ID: 36788092
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma.
Bosnakovski D; Ener ET; Cooper MS; Gearhart MD; Knights KA; Xu NC; Palumbo CA; Toso EA; Marsh GP; Maple HJ; Kyba M
Oncogenesis; 2021 Oct; 10(10):68. PubMed ID: 34642317
[TBL] [Abstract][Full Text] [Related]
28. CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression.
Smith SC; Buehler D; Choi EY; McHugh JB; Rubin BP; Billings SD; Balzer B; Thomas DG; Lucas DR; Goldblum JR; Patel RM
Mod Pathol; 2015 Jan; 28(1):57-68. PubMed ID: 24947144
[TBL] [Abstract][Full Text] [Related]
29. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.
Kawamura-Saito M; Yamazaki Y; Kaneko K; Kawaguchi N; Kanda H; Mukai H; Gotoh T; Motoi T; Fukayama M; Aburatani H; Takizawa T; Nakamura T
Hum Mol Genet; 2006 Jul; 15(13):2125-37. PubMed ID: 16717057
[TBL] [Abstract][Full Text] [Related]
30. CIC-DUX4 sarcomas.
Brahmi M; Vanacker H; Macagno N; Tirode F; Dufresne A
Curr Opin Oncol; 2022 Jul; 34(4):342-347. PubMed ID: 35730520
[TBL] [Abstract][Full Text] [Related]
31. The CAM Model for
Komatsu A; Matsumoto K; Yoshimatsu Y; Sin Y; Kubota A; Saito T; Mizumoto A; Ohashi S; Muto M; Noguchi R; Kondo T; Tamanoi F
Cells; 2021 Oct; 10(10):. PubMed ID: 34685592
[TBL] [Abstract][Full Text] [Related]
32. Important Recently Characterized Non-Ewing Small Round Cell Tumors.
Carter CS; Patel RM
Surg Pathol Clin; 2019 Mar; 12(1):191-215. PubMed ID: 30709443
[TBL] [Abstract][Full Text] [Related]
33. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor.
Siegele B; Roberts J; Black JO; Rudzinski E; Vargas SO; Galambos C
Am J Surg Pathol; 2017 Mar; 41(3):423-429. PubMed ID: 27879517
[TBL] [Abstract][Full Text] [Related]
34. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
[TBL] [Abstract][Full Text] [Related]
35. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
[TBL] [Abstract][Full Text] [Related]
36. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions.
Le Guellec S; Velasco V; Pérot G; Watson S; Tirode F; Coindre JM
Mod Pathol; 2016 Dec; 29(12):1523-1531. PubMed ID: 27562494
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Kito F; Sei A; Sugaya J; Nakagawa M; Yoshida A; Iwata S; Kawai A; Kondo T
Hum Cell; 2020 Apr; 33(2):427-436. PubMed ID: 31898195
[TBL] [Abstract][Full Text] [Related]
38. The "grep" command but not FusionMap, FusionFinder or ChimeraScan captures the CIC-DUX4 fusion gene from whole transcriptome sequencing data on a small round cell tumor with t(4;19)(q35;q13).
Panagopoulos I; Gorunova L; Bjerkehagen B; Heim S
PLoS One; 2014; 9(6):e99439. PubMed ID: 24950227
[TBL] [Abstract][Full Text] [Related]
39. Mapping chromatin state and transcriptional response in CIC-DUX4 undifferentiated round cell sarcoma.
Thomas NJ; Luck C; Shlimon N; Ponce RK; Kosibaty Z; Okimoto RA
bioRxiv; 2023 Oct; ():. PubMed ID: 37873100
[TBL] [Abstract][Full Text] [Related]
40. Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.
Ko JS; Marusic Z; Azzato EM; Farkas DH; Van Arnam J; Seiwerth S; Fritchie K; Patel RM; Rubin BP; Billings SD
J Cutan Pathol; 2020 Jun; 47(6):509-516. PubMed ID: 32026485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
